Assembly Biosciences, Inc. (ASMB)
35.60
-0.27
(-0.75%)
USD |
NASDAQ |
Dec 11, 12:30
Assembly Biosciences Total Liabilities (Quarterly): 57.30M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Arvinas, Inc. | 279.90M |
| Supernus Pharmaceuticals, Inc. | 370.09M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 240.00M |
| Shareholders Equity (Quarterly) | 182.70M |
| Debt to Equity Ratio | 0.0151 |
| Current Ratio | 4.436 |
| Net Debt Paydown Yield | -0.05% |